Has Leslie Radentz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $851 in general payments to Leslie Radentz, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leslie Radentz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leslie Radentz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leslie Radentz, MD

Dermatology · Murrieta, CANPI 1508974767

Payments from drug & device makers

$851in general payments, 2019–2025

Across 11 payments — averaging $77.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$243
Pfizer$154
Galderma Laboratories, L.p.$129
Bristol Myers Squibb$91
Ortho Dermatologics, A Division Of Bausch Health US, LLC$79
LEO Pharma Inc.$68
plus $87 from 2 others

What the payments were for

Food & beverage$851100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	2	$243
Pfizer	2	$154
Galderma Laboratories, L.p.	1	$129
Bristol Myers Squibb	1	$91
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$79
LEO Pharma Inc.	2	$68
Incyte Corporation	1	$52
E.r. Squibb & Sons, L.L.C.	1	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$243

How this compares

$851 in reported general payments places this provider in the 35th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024

$60,717

Medicare patients

167

Services billed

1,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tretinoin	28	$2,409
Ketoconazole	189	$2,254
Metronidazole	21	$988
Mupirocin	22	$234
Triamcinolone Acetonide	19	$76

Paid to pharmacies, not to this prescriber.

Other dermatology in Murrieta

Vivian LaquerIrvine$20.9M
Howard SofenLos Angeles$16.1M
Raja SivamaniSacramento$11.8M
Jennifer SoungSanta Ana$10.3M
Stacy SmithEncinitas$7.9M
Paul YamauchiSanta Monica$7.8M
Navid EzraThousand Oaks$7.8M
Paul WallaceBeverly Hills$7.1M
April ArmstrongLos Angeles$6.2M
David RayhanHuntington Beach$5.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →